Amyloidosis in adult rheumatoid arthritis is well documented (Table I) . Rosenberg, Baggenstoss, and Hench (1944) reported an incidence of 6-6 per cent. in a study of thirty post mortem cases and Unger, Zuckerbrod, Beck, and Steele (1948a) recorded a similar incidence (6 -9 per cent. in 58 cases), but Teilum and Lindahl (1954) found it in 60-7 per cent. of 28 post mortem cases. Missen and Taylor (1956) , reporting 47 cases from the Royal Postgraduate Medical School of London, and reviewing other large series in the literature, found a total of 385 cases and suggested 14-7 per cent. as a conservative estimate of the incidence of amyloidosis post mortem in adult rheumatoid arthritis. Fearnley and Lackner (1955) reported an incidence of 3 -8 per cent. in 181 cases, using a modified Congo red test and liver biopsy for diagnosis, whereas Arapakis and Tribe (1963) found an incidence of 5-2 per cent. in 115 cases, using rectal biopsy for diagnosis. (Trasoff, Schneeberg, and Scarf, 1944; James and Bolton, 1951 ; C.P.C. Boston, 1959; C.P.C. Hammersmith Hospital, 1964) and single juvenile cases have been reported among groups of adults (Reece and Reynolds, 1954; Parkins and Bywaters, 1959) . In reviewing series of cases of Still's disease (Table II) , Coss and Boots (1946) noted 1 -8 per cent. in 56 cases, Edstrom (1958) Lindbjerg (1964) reported three deaths (4 per cent.) from this cause among the 75 cases discussed. These series are small and have a variable degree of bias due to hospital selection. With a much larger group followed personally for a much longer period, we have therefore assessed the incidence of amyloidosis in our own cases ofjuvenile rheumatoid arthritis and have also assessed the outcome following diagnosis.
Material and Methods At the time of this study (1966) , 389 cases of definite Still's disease* have been investigated and are being followed by this Unit. The follow-up is from 1 to 25 years (mean 10 -9). Cases are seen routinely at least once a year until 10 years after onset, and then if the disease is inactive, at longer intervals unless review is requested by the general practitioner.
At each follow-up the whole disease process is graded as inactive, slightly active, or active, according to the presence or absence of pain and soft tissue swelling of the joints, due attention being paid to other features such as fever, rash, pericarditis, iridocyclitis, and erythrocyte sedimentation rate. In addition, a general examination -is-made, noting in particular enlargement of the liver, spleen, or glands, and any rise in blood pressure. The age at onset of the Still's disease in those who developed amyloidosis showed little difference from that in the group as a whole (Ansell and Bywaters, 1959) , with a peak incidence of onset in the amyloid cases occurring before the age of 5 years. The diagnosis of amyloidosis was made from 1 to 23 years (mean 8.2) after the onset of disease (Table (VI) . In three cases it was suspected clinically 1 to 4 years before it could be confirmed by acceptable methods. In one of these patients (Case 1) suspicion arose because of persistent splenomegaly without proteinuria and in the other two (Cases 9 and 10) because of continuous proteinuria. In the remaining thirteen cases the presenting sign of amyloidosis was proteinuria.
In the seven patients who died, amyloidosis had been present for from 4 months to 14 years (mean 8 years). As already indicated, the presence of amyloidosis was confirmed post mortem in the fous cases in which it was performed. The Congo red test had been positive in two of the other three cases and liver biopsy in one. The living cases have had proven amyloidosis for from 6 months to 10 years (mean 4 years), confirmation having been obtained by rectal biopsy in five, renal biopsy in one, and by a positive Congo red test in the remaining three. At the time of diagnosis of amyloidosis, fifteen of the sixteen patients had active arthritis and the remaining one had had a recurrence of mild arthritis after some years of inactivity. Fourteen out of the sixteen showed no rheumatoid factor in the serum and in the eight in which it was performed the anti-nuclear factor was negative. The erythrocyte sedimentation rate and haemoglobin gave no clear correlation. At the time of confirmation of amyloidosis, eight patients had hepatomegaly and seven splenomegaly; proteinuria was present in all but the blood urea was normal (Table VII) . The blood pressure was raised in two (Cases 9 and 10).
Discussion
The incidence of amyloidosis in this series is similar to that given by Lindbjerg (1964) but higher than in previously reported series of cases of Still's disease (Coss and Boots, 1946; Edstr6m, 1958; Schlesinger and others, 1961: Table II) . It is, however, similar to the results of Fearnley and Lackner (1955) and Arapakis and Tribe (1963) in adult rheumatoid arthritis (Table I) .
Taken as a whole Still's disease has a better prognosis than adult rheumatoid arthritis because the disease tends to become inactive in a greater proportion and because a good functional status is more often maintained (Ansell, 1965) . The probability of survival, however, is influenced by the development of amyloidosis which is a potentially fatal complication; in this series of patients developing amyloid who died, the average duration of life after diagnosis was 8-2 years. This means that, in appraising patients for general management, surgery, or subsequent training, proteinuria must always be specifically investigated.
It Confirmation has been complicated in the past by the interpretation of the Congo red test, and in patients with apparently uncomplicated rheumatoid arthritis an increased uptake of the dye has been found (Dixon, Ramcharan, and Ropes, 1955) . Furthermore, it is well known that a negative Congo red test may be coincident with positive histological findings (Blum and Sohar, 1962) . More recently, renal biopsy has been used; this remains the only sure method of confirming renal involvement, but is a potentially dangerous procedure especially in children, and we prefer rectal biopsy as the initial screening test. Ennevaara and Martti (1964) Bestetti, Pirani, and Catchpole (1958) reported that, if cortisone were given before or during casein treatment, the formation of amyloid was reduced or prevented. Gardner (1962) , comparing the post mortem incidence of amyloidosis in patients with rheumatoid arthritis in the precortisone and cortisone era, found a 9 3 and 12 5 per cent. incidence respectively, but such studies are subject to several sources of bias. In our series eleven of the sixteen had had corticosteroids before amyloidosis was diagnosed; this probably reflects the severity of the disease process. In cases with proven amyloidosis we have found that corticosteroids had no beneficial effect on the arthritis or the nephrotic syndrome, and in one the oedema became worse.
The problem of gold therapy is equally complex as in experimental animal studies Kirkpatrick and Sorenson (1965) have shown that casein-induced amyloidosis in mice previously treated with colloidal gold was greater than in a non-treated control group. Three of our patients had had gold therapy before amyloidosis was diagnosed, 4 years previously in Case 1 and 3 years in Case 6; in Case 16 proteinuria was noted for the first time during a course of gold. Chrysotherapy has been given to Cases 2 and 7 after amyloidosis was diagnosed in an attempt to control the activity of the Still's disease, but had little effect on either the disease process or the amyloidosis.
Four of our cases (2, 5, 7, and 14), however, had had neither corticosteroid nor gold therapy before amyloidosis was diagnosed, and it is, therefore, difficult to implicate either form of treatment in the genesis or development of amyloidosis.
Bland and Duarte (1963) , following an earlier report, treated a patient with rheumatoid arthritis with whole liver extract, and although the symptoms of amyloidosis improved a repeat renal biopsy showed no change in the amyloid infiltration.
Clinical remission of amyloidosis was reported by Parkins and Bywaters (1959) ; this patient who appears as Case 6 in this series following a recurrence of proteinuria died 3 years later in uraemia. We have seen remission in three other cases (5, 14, and 15) . Case 14 (see Appendix) developed amyloidosis after 4 years of active arthritis and in the next 3 years proteinuria recurred intermittently. Since then, the nephrotic syndrome has regressed, the serum protein has returned to normal, and the proteinuria has gone; the joint disease has been inactive for 6 of these 7 years. Case 15 (see Appendix) developed amyloidosis after 8 years of active arthritis, but in the following 6 years proteinuria was intermittent and has now regressed although the arthritis remains active. This last case is the only instance of remission of amyloidosis in this group associated with continued activity of Still's disease.
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